Drug Type Recombinant polypeptide, Biosimilar |
Synonyms Semaglutide Biosimilar (Taiji Group Chongqing Fuling Pharmaceutical Factory Co., Ltd.), 司美格鲁肽 生物类似药(太极集团重庆涪陵制药厂有限公司) |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | IND Approval | China | 09 Sep 2025 |